Scheuerer S[au] - Search Results

Year	Number of Results
1996	1
1998	2
2001	2
2005	1
2009	1
2010	1
2011	2
2017	2
2018	1
2019	1
2021	1

1

NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats.

Becker R, Gass N, Kußmaul L, Schmid B, Scheuerer S, Schnell D, Dorner-Ciossek C, Weber-Fahr W, Sartorius A. Becker R, et al. Among authors: scheuerer s. Psychopharmacology (Berl). 2019 Dec;236(12):3451-3463. doi: 10.1007/s00213-019-05310-3. Epub 2019 Jul 2. Psychopharmacology (Berl). 2019. PMID: 31267156

2

Computational approaches to predict drug metabolism.

Czodrowski P, Kriegl JM, Scheuerer S, Fox T. Czodrowski P, et al. Among authors: scheuerer s. Expert Opin Drug Metab Toxicol. 2009 Jan;5(1):15-27. doi: 10.1517/17425250802568009. Expert Opin Drug Metab Toxicol. 2009. PMID: 19236226 Review.

3

pH-dependent solubility and permeability profiles: A useful tool for prediction of oral bioavailability.

Sieger P, Cui Y, Scheuerer S. Sieger P, et al. Among authors: scheuerer s. Eur J Pharm Sci. 2017 Jul 15;105:82-90. doi: 10.1016/j.ejps.2017.04.016. Epub 2017 May 3. Eur J Pharm Sci. 2017. PMID: 28478135

4

Modeling energy intake and body weight effects of a long-acting amylin analogue.

Brings A, Borghardt JM, Skarbaliene J, Baader-Pagler T, Deryabina MA, Rist W, Scheuerer S. Brings A, et al. Among authors: scheuerer s. J Pharmacokinet Pharmacodyn. 2018 Apr;45(2):215-233. doi: 10.1007/s10928-017-9557-6. Epub 2017 Nov 23. J Pharmacokinet Pharmacodyn. 2018. PMID: 29170989

5

Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure.

Kley JT, Mack J, Hamilton B, Scheuerer S, Redemann N. Kley JT, et al. Among authors: scheuerer s. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5924-7. doi: 10.1016/j.bmcl.2011.07.083. Epub 2011 Aug 9. Bioorg Med Chem Lett. 2011. PMID: 21873051

6

Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations.

Hanft G, Türck D, Scheuerer S, Sigmund R. Hanft G, et al. Among authors: scheuerer s. Inflamm Res. 2001 Mar;50 Suppl 1:S35-7. doi: 10.1007/PL00000219. Inflamm Res. 2001. PMID: 11339520 Clinical Trial.

7

Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations.

Klueglich M, Ring A, Scheuerer S, Trommeshauser D, Schuijt C, Liepold B, Berndl G. Klueglich M, et al. Among authors: scheuerer s. J Clin Pharmacol. 2005 Sep;45(9):1055-61. doi: 10.1177/0091270005279579. J Clin Pharmacol. 2005. PMID: 16100300 Clinical Trial. No abstract available.

8

Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation.

Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M. Beiche F, et al. Among authors: scheuerer s. FEBS Lett. 1996 Jul 22;390(2):165-9. doi: 10.1016/0014-5793(96)00604-7. FEBS Lett. 1996. PMID: 8706851 Free article.

9

Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.

Euller-Ziegler L, Vélicitat P, Bluhmki E, Türck D, Scheuerer S, Combe B. Euller-Ziegler L, et al. Among authors: scheuerer s. Inflamm Res. 2001 Mar;50 Suppl 1:S5-9. doi: 10.1007/PL00022377. Inflamm Res. 2001. PMID: 11339521

10

An Integrative Approach for Improved Assessment of Cardiovascular Safety Data.

Wallman M, Scheuerer S, Martel E, Pairet N, Jirstrand M, Gabrielsson J. Wallman M, et al. Among authors: scheuerer s. J Pharmacol Exp Ther. 2021 May;377(2):218-231. doi: 10.1124/jpet.120.000348. Epub 2021 Mar 1. J Pharmacol Exp Ther. 2021. PMID: 33648939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results